BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 5391581)

  • 1. [Blood coagulation tests for plasma factors. Tatsumi factor].
    Umegaki K
    Rinsho Byori; 1969; 16():Suppl 16:105+. PubMed ID: 5391581
    [No Abstract]   [Full Text] [Related]  

  • 2. [Platelet factor 4 in congenital haemostatic disorders (author's transl)].
    Domingo albos A; Ortega Aramburu J; Castillo Cofino R; Domenech Mateu MD
    Sangre (Barc); 1976; 21(2):243-50. PubMed ID: 948776
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on plasma hypercoagulability. 1. Heparin resistance in various diseases and its relation to coagulation factors, anticoagulant therapy, platelet and heparin co-factor].
    Satake K
    Naika Hokan; 1969 Apr; 16(4):127-38. PubMed ID: 5816626
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hypercoagulability and lung embolism].
    Lechner K
    Verh Dtsch Ges Inn Med; 1978; (84):276-87. PubMed ID: 369194
    [No Abstract]   [Full Text] [Related]  

  • 5. Coagulation factor and platelet defect.
    Pati H; Saraya AK
    J Assoc Physicians India; 1987 Feb; 35(2):117-20. PubMed ID: 3693265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Blood coagulation disorders in a chronic eosinophilic leukemia].
    Zöller H
    Munch Med Wochenschr; 1973 Jun; 115(22):1036-8. PubMed ID: 4740866
    [No Abstract]   [Full Text] [Related]  

  • 7. [Assay of blood coagulation factors in factor deficiency plasma].
    Hino S
    Rinsho Ketsueki; 1989 Oct; 30(10):1903-4. PubMed ID: 2593258
    [No Abstract]   [Full Text] [Related]  

  • 8. Factor XIII in human plasma and platelets.
    McDonagh J; McDonagh RP; Delâge JM; Wagner RH
    J Clin Invest; 1969 May; 48(5):940-6. PubMed ID: 5780202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Round table conference. Tatsumi factor].
    Nihon Ketsueki Gakkai Zasshi; 1966 Jun; 29(3):445-56. PubMed ID: 6006096
    [No Abstract]   [Full Text] [Related]  

  • 10. Absent plasma second phase platelet aggregation factor in a patient with Hageman trait.
    Okonkwo P; Post R; Sise H
    Thromb Diath Haemorrh; 1970 Jun; 23(3):423-31. PubMed ID: 5432187
    [No Abstract]   [Full Text] [Related]  

  • 11. [Coagulation disorders in patients with liver cirrhosis].
    Ihle E; Schimmelpfennig W
    Z Arztl Fortbild (Jena); 1983; 77(22):929-34. PubMed ID: 6659589
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation factors and atherosclerosis].
    Facchini G
    Bull Sci Med (Bologna); 1967; 139(4):460-73. PubMed ID: 5606046
    [No Abstract]   [Full Text] [Related]  

  • 13. Increased prothrombinase binding sites in unstimulated platelets from a protein C deficient patient.
    Scully MF; Ellis V; Melissari E; Kakkar VV
    Thromb Haemost; 1984 Jul; 51(3):407. PubMed ID: 6548586
    [No Abstract]   [Full Text] [Related]  

  • 14. [Some blood coagulation factors in malignant tumors].
    Kosmala U; Noceń A
    Przegl Lek; 1968; 24(8):633-6. PubMed ID: 5758000
    [No Abstract]   [Full Text] [Related]  

  • 15. Altered blood coagulation in patients with posttraumatic stress disorder.
    von Känel R; Hepp U; Buddeberg C; Keel M; Mica L; Aschbacher K; Schnyder U
    Psychosom Med; 2006; 68(4):598-604. PubMed ID: 16868270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The laboratory approach to inherited and acquired coagulation factor deficiencies.
    Wagenman BL; Townsend KT; Mathew P; Crookston KP
    Clin Lab Med; 2009 Jun; 29(2):229-52. PubMed ID: 19665676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Hemorrhagic disease of the newborn. New pathogenetic trends].
    Grasso E; Vaccari A
    Minerva Pediatr; 1968 Jun; 20(22):1139-69. PubMed ID: 5736009
    [No Abstract]   [Full Text] [Related]  

  • 18. [Principles of the differential diagnosis of blood coagulation disorders].
    Polubiec A
    Pol Tyg Lek; 1983 Aug; 38(31):953-7. PubMed ID: 6664913
    [No Abstract]   [Full Text] [Related]  

  • 19. [Characteristics and use of blood transfusion and blood components in the treatment of patients with hemostasis disorders: II. Levels of coagulation factors].
    Grgicević D; Pistotnik M
    Lijec Vjesn; 1986 Jun; 108(6):274-7. PubMed ID: 3724356
    [No Abstract]   [Full Text] [Related]  

  • 20. Circulating anticoagulants against factors IX and XI in systemic lupus erythematosus.
    Castro O; Farber LR; Clyne LP
    Ann Intern Med; 1972 Oct; 77(4):543-8. PubMed ID: 4642734
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.